(Q36719024)
Statements
1 reference
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial (English)
1 reference
C S Fuchs
S Azevedo
T Okusaka
J-L Van Laethem
L R Lipton
H Riess
M J Moore
G Bodoky
M Ikeda
B Melichar
R Nemecek
S Ohkawa
A Świeboda-Sadlej
S A Tjulandin
E Van Cutsem
R Loberg
V Haddad
J L Gansert
B A Bach
21 January 2015
1 reference